Modified TOMOX-HAIC in Combination With Sintilimab and Bevacizumab Biosimilar for First-line Treatment of Advanced Hepatocellular Carcinoma
Clinical trial NCT06285019 · UNKNOWN
Trial details
- NCT number
- NCT06285019
- Sponsor
- Fudan University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2023-12-01
- Primary completion
- 2024-12-31
- Enrollment
- 65
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.